Meraj Ramezani, Ph.D.

Meraj Ramezani is a research scientist I in the type 2 diabetes systems genomics group in the Metabolism Program at the Broad Institute of MIT and Harvard, working under the direction of J.T. Neal. The goal of his research is to develop and deploy high throughput multiplexed pooled optical screening tools and analysis pipelines. These pipelines use data science and machine learning solutions to gain insight into disease mechanisms and enable therapeutic discovery. He has been co-leading the PERISCOPE project in collaboration with the Broad Imaging Platform and Calico. PERISCOPE aims to develop and deploy high throughput optical screening techniques based on morphological profiles to understand the mechanism of diseases and discover new drug targets.

Ramezani joined the Broad Institute in 2021 after completing postdoctoral studies at Cornell University. He earned his Ph.D. in chemistry and chemical biology (focused in biophysics) from Cornell University and holds M.Sc./ B.S. degrees in chemistry from the Sharif University of Technology.